Research Data from Public Assistance - Paris Hospitals (AP-HP) Update Understanding of Non-Small Cell Lung Cancer (First-line angiogenesis inhibitor plus erlotinib versus erlotinib alone for advanced non-small-cell lung cancer harboring an EGFR ...)

Source :: Obesity, Fitness & Wellness Week. July 25, 2020, 764
Publication Year :: 2020
Abstract: 2020 JUL 25 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Research findings on Oncology - Non-Small Cell Lung Cancer are discussed in [...]

Subjects :: Public assistance -- Research
Physical fitness -- Research
Ramucirumab -- Research
Bevacizumab -- Research
Vascular endothelial growth factor -- Research
Small cell lung cancer -- Care and treatment -- Research
Erlotinib -- Research
Non-small cell lung cancer -- Research -- Care and treatment
Health

Tools